Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1.
Saved in:
| Title: | Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. |
|---|---|
| Authors: | Tomczak K; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel MS; Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Bhalla AD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Landers SM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Callahan SC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhang D; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wong J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Landry JP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Guadagnolo BA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lyu HG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lillemoe H; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roland CL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Scally CP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hunt KK; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McCutcheon IE; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Slopis JM; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gu J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Scheet P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang L; Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Rai K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres KE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | Molecular carcinogenesis [Mol Carcinog] 2025 Jan; Vol. 64 (1), pp. 44-56. Date of Electronic Publication: 2024 Nov 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
